Chen Fei resigned as Tong Ren Tang Chinese Medicine's (HKG:3613) executive deputy general manager and an executive director effective Monday, a same-day Hong Kong bourse filing said.
The resignation came about due to a change in work arrangement.
The medicine maker, on the same day, named Yue Zheng as an executive director and vice chairman of the board.
Yue has been a part of the Beijing Tong Ren Tang Group in June 2003 and joined the company in September 2022.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.